AMGN compared with NVAX: revenue, margins and what each company keeps, and the suppliers and customers both name

AMGNAmgen Inc

Mkt capRevenueRevenue

NVAXNovavax Inc

Mkt capRevenueRevenue

Compare

AMGNAmgen Inc

NVAXNovavax Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

AMGNAmgen Inc

460.55▲+0.06%· post 460.50· delayed

Mkt cap$249.0BRevenue$10.4BQ3 FY26Revenue$36.8BFY25

NVAXNovavax Inc

10.76▲+10.02%· post 10.76· delayed

After hoursNov 6 '26delayed

Mkt cap$1.6BRevenue$68MQ3 FY26Revenue$1.1BFY25

Compare

After hoursNov 6 '26delayed

AMGNAmgen Inc

NVAXNovavax Inc

460.55▲+0.06%post 460.50delayed

Price

10.76▲+10.02%post 10.76delayed

$249.0B

Mkt cap

$1.6B

Q3 FY26$10.4B

Revenue

$68MQ3 FY26

FY25$36.8B

Revenue

$1.1BFY25

AMGN460.55▲+0.06%vsNVAX10.76▲+10.02%After hoursNov 6 '26delayed

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

NVAX: latest quarter is a loss; flow not drawable.Method ›

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only AMGN 12

PODDInsuletsupplier

CYTKCytokineticssupplier

ARWRArrowhead Pharmaceuticalssupplier

LGNDLigand Pharmaceuticalssupplier

8 more · AMGN chain ›

Shared 0

No shared counterparties.

Only NVAX 13

PFEPfizer Inc. ("Pfizer")customer

SNYSanoficustomer

TAKTakedacustomer

—AGC Biologicsunlisted

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

supplier

9 more · NVAX chain ›

Price

rebased to 0%

AMGN, solidNVAX, dashed